Mark Whipple, M.D., M.S.
Mark Whipple, MD, MS graduated from the University of Washington School of Medicine and completed his Otolaryngology-Head & Neck Surgery training at the University of Illinois in Chicago. He practiced in his home town of Fairbanks, AK for several years before receiving graduate training in Biomedical Informatics in the Harvard-MIT program. He then Joined the department of Oto/HNS at UW in 2001. He has served as chief of Oto/HNS at Harborview Medical Center since 2007. In addition to his clinical activities, Dr. Whipple teaches in the UW medical school and does research in biomedical informatics.
Undergraduate Education: Stanford University, Palo Alto CA, 1987
Medical School: University of Washington, Seattle WA, 1991
Internship: University of Illinois, Chicago IL, 1992
Residency: University of Illinois, Chicago IL, 1996
Fellowship: Boston Children's Hospital, Research Fellowship in Bioinformatics, 2001
Other Training: Master's in Medical Informatics, Massachusetts Institute of Technology, 2001
Board Certification: Otolaryngology, 1997
Memberships: Fellow, American College of Surgeons
Awards and honors
2009: Harborview CARES Award for Service Excellence
2009: American Academy of Otolaryngology-Head & Neck Surgery Honor Award
2007: University of Washington School of Medicine Service Excellence Award
2002: UW Dept of Oto/HNS Trachey Award for Contributions to Resident Research
1995: Chicago Laryngologic and Otologic Society, Lederer-Pierce Prize for Resident Research
1991: Graduation with Honors, University of Washington School of Medicine
1990: Alpha Omega Alpha, University of Washington School of Medicine
1987: Graduation with Distinction, Stanford University
Dr. Whipple practices all aspects of adult otolaryngology with particular interest in the surgical management of craniofacial trauma.
Dr. Whipple's research has focused on informatics approaches to better understand the development and metastasis of head and neck neoplasms. Specific efforts include developing algorithms to identify tumor biomarkers, genomic and micro-RNA analyses, and computational models of tumor spread.